Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Julphar
Farmers Insurance
Deloitte
McKesson
Citi

Generated: March 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Fotemustine

« Back to Dashboard

US Patents for Fotemustine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fotemustine ➤ Sign Up Heat shock protein 70 (hsp-70) receptor ligands Duke University (Durham, NC) ➤ Sign Up
Fotemustine ➤ Sign Up Compounds and their methods of use Agios Pharmaceuticals, Inc. (Cambridge, MA) ➤ Sign Up
Fotemustine ➤ Sign Up Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus Seattle Genetics, Inc. (Bothell, WA) ➤ Sign Up
Fotemustine ➤ Sign Up Anti-FGFR3 antibodies and methods using same Genentech, Inc. (South San Francisco, CA) ➤ Sign Up
Fotemustine ➤ Sign Up Method of diagnosing and treating cancer using B-catenin splice variants The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) ➤ Sign Up
Fotemustine ➤ Sign Up Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC) ➤ Sign Up
Fotemustine ➤ Sign Up Use of inhibitors of Bruton'S tyrosine kinase (Btk) Pharmacyclics LLC (Sunnyvale, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Fotemustine

Drugname Country Document Number Estimated Expiration Related US Patent
Fotemustine World Intellectual Property Organization (WIPO) 2015148714 2034-03-25 ➤ Sign Up
Fotemustine Australia 2015231053 2034-03-21 ➤ Sign Up
Fotemustine Brazil 112016021620 2034-03-21 ➤ Sign Up
Fotemustine Canada 2943339 2034-03-21 ➤ Sign Up
Fotemustine China 106231900 2034-03-21 ➤ Sign Up
Fotemustine Eurasian Patent Organization 201691896 2034-03-21 ➤ Sign Up
Fotemustine European Patent Office 3119199 2034-03-21 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
McKesson
Moodys
Express Scripts
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.